Literature DB >> 22314739

Atrial fibrillation, physical activity and endurance training.

Sidsel Graff-Iversen1, Knut Gjesdal, Astanand Jugessur, Marius Myrstad, Wenche Nystad, Randi Selmer, Dag S Thelle.   

Abstract

INTRODUCTION: Clinical practice and the results of some studies may indicate that physical exercise in the form of endurance training may influence the development of atrial fibrillation (AF). The aim of this paper is to evaluate the scientific background for the hypothesis that there is a connection between physical activity and AF. MATERIAL AND
METHOD: This paper is a review article based on searches in PubMed on specific topics, limited to the period 1995 through March 2011. We found 17 original articles and three relatively recent reviews. Each was read by at least two of the authors and then discussed. Seven of the original articles were excluded for methodological reasons, and we therefore discuss the other ten.
RESULTS: We found support for the hypothesis that systematic high intensity endurance training such as running can increase the risk of AF, whereas the studies provide no evidence that less intensive physical exercise such as walking increases the risk. Several of the studies have methodological weaknesses.
INTERPRETATION: Important questions remain unanswered. There is a need for more studies that can shed light on the connection between training intensity, total volume of intensive endurance training, age-related changes and AF. Studies that include women are also needed.

Entities:  

Mesh:

Year:  2012        PMID: 22314739     DOI: 10.4045/tidsskr.11.0567

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  11 in total

1.  How Much Exercise Is Too Much.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-02-12

2.  Physical activity, resting heart rate, and atrial fibrillation: the Tromsø Study.

Authors:  Bente Morseth; Sidsel Graff-Iversen; Bjarne K Jacobsen; Lone Jørgensen; Audhild Nyrnes; Dag S Thelle; Peter Vestergaard; Maja-Lisa Løchen
Journal:  Eur Heart J       Date:  2016-03-10       Impact factor: 29.983

Review 3.  [Atrial fibrillation and physical activity. An overview].

Authors:  R Laszlo; J M Steinacker
Journal:  Herz       Date:  2015-09-25       Impact factor: 1.443

4.  Physical activity, symptoms, medication and subjective health among veteran endurance athletes with atrial fibrillation.

Authors:  Marius Myrstad; Marit Aarønæs; Sidsel Graff-Iversen; Inger Ariansen; Wenche Nystad; Anette Hylen Ranhoff
Journal:  Clin Res Cardiol       Date:  2015-07-26       Impact factor: 5.460

Review 5.  Atrial fibrillation and physical activity: Should we exercise caution?

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2015-12       Impact factor: 3.275

6.  Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation.

Authors:  Torbjørn Wisløff; Gunhild Hagen; Marianne Klemp
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

7.  Increased risk of atrial fibrillation among elderly Norwegian men with a history of long-term endurance sport practice.

Authors:  M Myrstad; M-L Løchen; S Graff-Iversen; A K Gulsvik; D S Thelle; H Stigum; A H Ranhoff
Journal:  Scand J Med Sci Sports       Date:  2013-11-21       Impact factor: 4.221

8.  Physical Activity and Risk of Atrial Fibrillation: A Nationwide Cohort Study in General Population.

Authors:  Moo-Nyun Jin; Pil-Sung Yang; Changho Song; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Jung-Hoon Sung; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Sci Rep       Date:  2019-09-13       Impact factor: 4.379

9.  [Descriptive and comparative study of cardiovascular risk factors and physical activity in patients with acute coronary syndrome].

Authors:  Maria Isabel Vazquez-Arce; Elena Marques-Sule
Journal:  Aten Primaria       Date:  2017-08-23       Impact factor: 1.137

Review 10.  Atrial Fibrillation in Athletes-Features of Development, Current Approaches to the Treatment, and Prevention of Complications.

Authors:  Evgeny Achkasov; Sergey Bondarev; Victor Smirnov; Zbigniew Waśkiewicz; Thomas Rosemann; Pantelis Theodoros Nikolaidis; Beat Knechtle
Journal:  Int J Environ Res Public Health       Date:  2019-12-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.